Andritz Lifts Revenue 9.2% as Order Intake Stays Above €2 Billion for Eighth Straight Quarter
Published on 11/12/2026 at 06:01 | Editorial boerse-global.de
Andritz closed Wednesday's session at €85.40, a gain of 2.9%, after the Austrian plant engineer confirmed it had commissioned a second acid regeneration unit at JSW Steel Coated Products Limited's Vasind works in India. The installation, announced on 5 November, processes 6,400 litres of spent pickling acid per hour and, according to the company, covers roughly 99% of the site's acid requirement for pickling operations.
The project news landed alongside a third-quarter report card that shows the group's top line and its order book pulling in different directions. Revenue for the three months to the end of September 2026 came in at €2.06bn, up 9.2% year on year. Order intake, reported on 29 October, reached €2.17bn — 0.6% below the prior-year quarter, yet still the eighth consecutive quarter above the €2bn mark.
That divergence sits at the heart of the investment case. Intake of €2,166.2m against revenue of €2,059.6m means Andritz booked more new business than it billed during the quarter, but the year-on-year decline raises the question of how long revenue can keep climbing without a matching recovery in orders. For the nine months to September, order intake totalled €8.09bn, an increase of 17.1% on the same period a year earlier.
Profitability held the line. The comparable EBITA margin came in at 9.0% for the quarter, inside the 8.7%–9.1% corridor management has set for the full year. Net profit for the period advanced 14.4% to €127.3m.
Should investors sell immediately? Or is it worth buying Andritz?
Guidance for 2026 was reaffirmed in full: revenue of €8.0bn to €8.3bn, with the comparable EBITA margin expected to stay within the same 8.7%–9.1% range. Hitting those targets would be a more convincing signal if new orders were expanding again at the same time; target delivery on its own carries less weight than target delivery accompanied by firmer demand.
The bull case therefore rests on a combination rather than a single metric — Andritz defending its margin while pulling order intake back into growth. A weaker reading would gain credibility if falling bookings coincided with deteriorating profitability, since that would undermine both the growth story and the quality of earnings at once.
Operationally, the Vasind commissioning offers a tangible reference point. It is the second such unit Andritz has brought online at the Indian site, and the 99% acid coverage figure underlines the kind of recurring service and equipment work that feeds the order book.
Andritz at a turning point? This analysis reveals what investors need to know now.
Investors get their next scheduled checkpoint on 4 March 2027, when Andritz publishes its full-year 2026 results. Before then, the group will be on the road at the Berenberg Pan-European Discovery Conference USA, running from 17 to 18 November 2026. Until the annual figures land, the read-across will hinge on whether further announcements show orders, revenue and margin moving in the same direction — a combination that would justify a more constructive view, while continued order weakness would lend weight to the cautious one.
Ad
Andritz Stock: New Analysis - 12 November
Fresh Andritz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
